
51 - 200 employees
🏥 Healthcare
💼 Consulting
🧬 Biotechnology
Healthcare • Consulting • Biotechnology
BBOT is a biotechnology company developing targeted therapies for cancers driven by RAS signaling and PI3Kα. The company focuses on rational drug design to inhibit the active ON state of RAS and to selectively block RAS-driven PI3K activation, aiming at multiple KRAS mutants and novel approaches to maximize target inhibition. BBOT translates decades of RAS biology research into therapeutic candidates intended to improve outcomes for patients with RAS- and PI3Kα-driven tumors.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 August 21
Translational medicine leader advancing BBOT’s RAS/PI3K oncology pipeline. Owning biomarker strategy from IND-enabling studies through clinical proof of concept.
🇺🇸 United States – Remote
💵 $235k - $310k / year
⏰ Full Time
🟠 Senior
🌎 Translator / Interpreter
👻 Ghost score 0%
🕒 July 28
Director of Regulatory Affairs leading submission strategy for oncology development programs in a biotech firm. Overseeing regulatory submissions and providing strategic recommendations for product development.
🕒 July 28
Associate Director of Drug Product Development at BBOT leading formulation and process development for small molecules. Essential role in advancing programs from preclinical through commercial stages in a mission-driven biotech team.
🕒 July 17
Director of Medical Writing responsible for strategic leadership and document delivery at BridgeBio Oncology Therapeutics. Leading complex regulatory submissions with a focus on oncology therapeutics.
🕒 July 3
Director or Senior Director providing scientific and strategic leadership across oncology pipeline at BridgeBio. Overseeing clinical pharmacology strategy and collaborating with cross-functional teams.
🇺🇸 United States – Remote
💵 $200k - $280k / year
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 12%